查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466143

去肾神经设备市场：按技术、产品、疾病应用和最终用户划分 - 全球预测 2024-2030

Renal Denervation Devices Market by Technology (Micro-Infusion-Based, Pharmacologic Ablation, Radiofrequency-Based), Products (Catheters, Nerve Modifying Agents, RF Generator), Disease Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

肾臟去神经设备市场规模预计2023年为2.3629亿美元，2024年达2.6644亿美元，预计2030年将达到5.7985亿美元，复合年增长率为13.68%。

去肾交感神经装置是医疗设备。这些设备透过针对肾动脉周围多余的交感神经提供了另一种解决方案，肾动脉在调节血压方面发挥关键作用，并有助于高血压的发展。由于生活方式的改变，全球人群难治性高血压的盛行率不断增加，人们越来越意识到去肾神经术相对于传统药物治疗的好处，以及老年人口的增加正在推动去肾神经术设备市场的成长。然而，去肾神经装置、相关程序和一些严格的法律规范的高成本可能会阻碍市场成长。设备设计和技术方面的技术进步正在提高肾去神经术治疗的功效和安全性，并有望创造利润丰厚的市场机会。

主要市场统计
基准年[2023] 2.3629亿美元
预测年份 [2024] 26644万美元
预测年份 [2030] 57985万美元
复合年增长率（%） 13.68%

技术：基于超音波的肾臟去神经技术的采用率很高

基于微量输注的肾去神经术涉及将少量抗高血压药物直接注入肾动脉周围的空间。这种有针对性的方法可以最大限度地减少全身副作用并提高药物疗效。药物消融使用神经毒性药物（例如酒精或胍乙啶）以化学方式破坏过度活跃的肾臟神经。当由于解剖复杂性或禁忌症而无法采用射频或超音波方法时，首选此手术。射频肾去神经术涉及应用受控电能来破坏目标肾神经。该方法因其准确性、安全性和降低血压的有效性而受到青睐。基于超音波的肾去神经术使用高频声波产生局部热量来破坏过度活跃的肾神经。这种非侵入性方法对于有禁忌症或对其他方法过敏的患者很有吸引力。

产品多电极导管因其手术时间短而被广泛使用。

导管是肾臟去神经手术中使用的主要设备，它提供射频能源来消融或改变引起高血压的神经。导管主要用于其微创性和针对特定神经的精确性。多电极导管的尖端有多个电极，可以同时消融多个神经部位，这可能会减少手术时间并提高疗效。神经调节剂是与肾臟去神经装置搭配使用的药物，可改善手术结果。这些药物可改善患者的整体反应或最大程度地减少手术中可能出现的併发症。 RF（射频）产生器是肾臟去神经手术中使用的重要设备，可将受控能量传递到消融神经的导管。单电极导管的尖端有一个电极，用于顺序消融神经部位。这些导管可以更精确地瞄准特定神经，但该过程可能比多电极导管花费更长的时间。

疾病应用：扩大去肾神经装置在高血压治疗的应用

去肾神经装置已成为糖尿病合併高血压和肾臟病病患者的有效治疗方法。去肾神经装置可抑制交感神经的过度活跃，进而加剧糖尿病併发症。在心臟衰竭患者中，交感神经活动增加，导致血压升高和体液超负荷，这是肾臟损伤进展的因素。去肾神经治疗可以有效抑制这些患者的交感神经亢进，改善心臟功能和整体生活品质。在高血压中，去肾神经支配透过损害肾交感神经并减少其对血压调节的影响来帮助降低血压。去肾神经装置被认为是慢性肾臟病（CKD）患者的潜在治疗选择，这些患者经常患有高血压和糖尿病併发症。这种调节交感神经系统的治疗方法可能有助于减缓 CKD 的进展并减轻与肾功能障碍相关的症状。

最终用户：门诊医疗中心偏好去肾神经装置作为微创且经济高效的解决方案

门诊护理中心 (ACC) 是一家门诊设施，提供各种医疗服务，包括肾臟相关疾病的诊断和治疗，并为高血压患者的管理提供去肾神经装置。 ACC 青睐微创、经济高效的解决方案，以确保患者的安全和舒适，同时最大限度地提高业务效率。诊断中心和医院对于透过早期发现和介入来控制高血压至关重要。随着全球范围内不受控制的高血压和抗药性病例的增加，这些设施需要先进的去肾神经设备来优化患者的治疗效果。医院在选择去肾神经装置时优先考虑易用性、对现有设备的适应性以及强大的临床资料支援。研究机构和学术中心处于高血压治疗的最前沿，开发肾臟去神经术的新治疗方法和设备。这些组织专注于具有强有力临床证据的最尖端科技，以支持该领域的未来发展。

区域洞察

市场状况很重要，因为美洲人口中高血压盛行率很高，并且在新治疗方法的研究上投入了大量资金。技术的进步和医疗保健专业人员对创新治疗方法的认识不断提高正在推动对这些设备的需求。由于各国对去肾神经疗法的认识不断提高以及有利的报销政策，欧盟显示出巨大的市场成长潜力。高血压预防和管理方面的合作正在加速该领域的研究和开发倡议。由于高血压盛行率不断上升，加上生活方式的改变和都市化，中东和非洲地区是去肾神经装置的一个前景广阔的市场。在亚太地区，由于政府对高血压研究的资助和倡议，临床试验和专利申请的数量正在增加。强大的医疗基础设施、对技术进步的浓厚兴趣、高血压管理意识的提高以及医疗设施的改善正在促进该地区去肾神经设备市场的成长。

FPNV定位矩阵

FPNV定位矩阵对于评估去肾神经装置市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对肾去神经设备市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.去肾神经装置市场的市场规模和预测是多少？

2.在肾臟去神经设备市场预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.去肾神经器材市场的技术趋势和法规结构是什么？

4.去肾神经设备市场主要供应商的市场占有率是多少？

5. 进入去肾神经器材市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着人口老化，慢性肾衰竭的盛行率不断增加
      • 微创手术的日益普及与趋势
    • 抑制因素
      • 与去肾神经装置相关的高成本
    • 机会
      • 肾臟去神经装置的技术进步与改进
      • 继续出版肾去神经术的临床指引和越来越多的临床评估研究
    • 任务
      • 关于产品核可的严格政府法规和缺乏经验丰富的医疗保健专业人员
  • 市场区隔分析
    • 技术：超音波肾神经切除技术采用率高
    • 产品：增加多电极导管的使用以减少手术时间
    • 疾病应用：增加去肾神经装置在高血压治疗的使用
    • 最终用户：门诊护理中心偏好去肾神经装置作为微创且经济高效的解决方案。
  • 市场趋势分析
    • 在美洲，由于医疗设备製造商的存在以及医疗专业人员日益增长的支持，政府对去肾神经设备的核准一直很有利。
    • 扩大政府支持以改善高血压的诊断和治疗，并增加亚太地区去肾臟神经装置临床试验的正面结果
    • 支持全部区域肾神经装置的政府措施和核准流程
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章去肾臟神经设备市场：依技术分类

  • 微输液底座
  • 药物消融
  • 射频基地
  • 超音波基地

第七章肾臟去神经设备市场：副产品

  • 导管
  • 神经调节剂
  • 射频发生器

第八章去肾神经装置市场依疾病分类的应用

  • 糖尿病
  • 心臟衰竭
  • 高血压
  • 肾衰竭

第九章去肾神经装置市场：依最终用户分类

  • 门诊治疗中心
  • 诊断中心和医院
  • 研究和学术

第10章美洲去肾神经装置市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太去肾臟神经设备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲去肾神经装置市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Record Medical 和 Otsuka Medical Devices 宣布推出首个获得 FDA核准的用于高血压治疗的肾臟去神经系统
    • FDA核准Verve Medical 的 IDE 肾盂去神经术研究
    • 韩国Start-UpsKalos 获得 350 万美元津贴，用于开发治疗高血压的去肾神经装置
    • 德国正在进行超音波术抗治疗性高血压的早期疗效评估
    • Andera Partners 投资了一家医疗技术公司 SoniVie，该公司正在开发一种有前途的治疗高血压的设备
    • 法国Medtronic生产的肾臟去神经导管 SYMPLICITY SPYRAL 过渡盖
    • 上海金叶医疗科技有限公司获数百万人民币C轮融资
    • SPYRAL HTN-ON MED 试验证明了有意义的临床益处，与其他 SPYRAL HTN 肾臟去神经试验一致
    • Sonivee 获得 FDA 的 IDE核准，用于使用肾动脉神经阻断 TIVUS 技术治疗高血压的先驱性研究
    • Ablative Solutions 在 D 轮资金筹措中筹集了 9,140 万美元
    • Clinical Accelerator 宣布与 Verve Medical 合作进行抗治疗性的早期人体可行性研究

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-957C47F91FC5

[192 Pages Report] The Renal Denervation Devices Market size was estimated at USD 236.29 million in 2023 and expected to reach USD 266.44 million in 2024, at a CAGR 13.68% to reach USD 579.85 million by 2030.

Renal denervation devices are medical tools that provide minimally invasive therapy for patients suffering from drug-resistant hypertension or high blood pressure that do not respond adequately to conventional pharmacological therapies. These devices offer an alternative solution by targeting the overactive sympathetic nerves surrounding the renal arteries, which play a crucial role in regulating blood pressure and contribute to the development of hypertension. The increasing prevalence of resistant hypertension among the global population due to lifestyle changes, rising awareness about the benefits of renal denervation procedures over conventional drug therapies, and the growing geriatric population are driving the renal denervation devices market growth. However, the high cost of renal denervation devices, associated procedures, and several stringent regulatory frameworks may hamper market growth. Technological advancements in device design and procedural techniques have improved efficacy and safety profiles for renal denervation treatments, which is expected to create a lucrative market opportunity.

KEY MARKET STATISTICS
Base Year [2023] USD 236.29 million
Estimated Year [2024] USD 266.44 million
Forecast Year [2030] USD 579.85 million
CAGR (%) 13.68%

Technology: High adoption of ultrasound-based renal denervation technology

Micro-infusion-based renal denervation involves delivering small doses of anti-hypertensive drugs directly into the periarterial space surrounding the renal arteries. This targeted approach minimizes systemic side effects and improves drug efficacy. Pharmacologic ablation involves chemically destroying overactive renal nerves using neurotoxic agents such as alcohol or guanethidine. This technique is preferred when radiofrequency or ultrasound-based approaches are not feasible due to anatomical complexities or contraindications. Radiofrequency-based renal denervation involves applying controlled electrical energy to destroy targeted renal nerves. This method is preferred for its precision, safety, and effectiveness in reducing blood pressure. Ultrasound-based renal denervation uses high-frequency sound waves to generate localized heat that disrupts overactive renal nerves. This non-invasive technique makes it attractive for patients with contraindications or sensitivities to other methods.

Product: Significant use of multi-electrode catheters for their shorter-time of procedures

Catheters are the primary device used in renal denervation procedures to deliver radiofrequency energy to ablate or modify nerves responsible for hypertension. They are primarily used for their minimally invasive nature and precision in targeting specific nerves. Multi-electrode catheters have multiple electrodes on the tip that enable simultaneous ablation of multiple nerve sites, reducing procedure time and potentially increasing efficacy. Nerve-modifying agents are pharmaceuticals that work alongside renal denervation devices to enhance procedural outcomes. These agents may improve overall patient response or minimize potential complications arising from the procedure. An RF (Radiofrequency) generator is an essential device used in renal denervation procedures for providing controlled energy to catheters to ablate nerves. Single electrode catheters feature a single electrode at the tip and are used for sequential ablation of nerve sites. These catheters offer greater precision in targeting specific nerves but may require longer procedures than multi-electrode variants.

Disease Application: Proliferating use of renal denervation devices for treating hypertension

Renal denervation devices have emerged as an effective treatment for diabetic patients suffering from hypertension and nephropathy. These devices modulate the overactive sympathetic nervous system responsible for worsening diabetic complications. Heart failure patients experience high sympathetic activity, leading to increased blood pressure and fluid overload factors contributing to progressive kidney damage. Renal denervation therapy can effectively reduce sympathetic hyperactivity in these patients, improving cardiac function and overall quality of life. In hypertension, renal denervation helps lower blood pressure by disrupting the renal sympathetic nerves, reducing their influence on blood pressure regulation. Renal denervation devices are being explored as a potential treatment option for chronic kidney disease (CKD) patients who often suffer from hypertension and diabetic complications. The therapy's ability to modulate the sympathetic nervous system may help slow CKD progression and alleviate symptoms associated with kidney dysfunction.

End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution

Ambulatory care centers (ACCs) are outpatient facilities that provide various medical services, including diagnosis and treatment for kidney-related diseases, and offer renal denervation devices to manage patients with hypertension. ACCs prefer minimally invasive and cost-effective solutions to ensure patient safety and comfort while maximizing operational efficiency. Diagnostic centers and hospitals are crucial in managing hypertension through early detection and intervention. With a growing global prevalence of uncontrolled hypertension and drug-resistant cases, these institutions require advanced renal denervation devices for optimal patient outcomes. Hospitals prioritize ease of use, adaptability with existing equipment, and robust clinical data support when selecting renal denervation devices. Research institutions and academic centers are at the forefront of hypertension management, developing novel therapies and devices for renal denervation. These organizations focus on cutting-edge technology with strong clinical evidence to support future advancements in the field.

Regional Insights

The Americas has a significant landscape in the renal denervation devices market due to a high prevalence of hypertension among its population and substantial investments in research for novel therapies. Advancements in technology and growing awareness about innovative treatment options amongst healthcare professionals have fueled demand for these devices. The EU shows significant potential for market growth owing to increased awareness about renal denervation therapy and favorable reimbursement policies across countries. Collaborative efforts on hypertension prevention and control have accelerated R&D initiatives in this domain. The MEA region holds promising opportunities for renal denervation devices due to a rising incidence of hypertension coupled with lifestyle changes and urbanization. In the APAC region, government funding and initiatives for hypertension research resulted in a growing number of clinical trials and patent filings. Robust healthcare infrastructure, a strong focus on technological advancements, increased awareness about hypertension management, and improved healthcare facilities have contributed to the region's renal denervation devices market growth.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Renal Denervation Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Renal Denervation Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Renal Denervation Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Ablative Solutions, Inc., AngioDynamics, Inc., Aria CV, Inc., AtriCure, Inc., Bio-Heart, Boston Scientific Corporation, Cardinal Health, Inc., Kalos Medical, Medtronic PLC, Mercator MedSystems, Inc., Otsuka Holdings Co., Ltd., Shanghai Meiliweiye Medical Technology Co., Ltd., SoniVie, Symap Medical, Ltd., Symple Surgical, Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Renal Denervation Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Technology
    • Micro-Infusion-Based
    • Pharmacologic Ablation
    • Radiofrequency-Based
    • Ultrasound-Based
  • Products
    • Catheters
      • Multi Electrode Catheter
      • Single Electrode Catheter
    • Nerve Modifying Agents
    • RF Generator
  • Disease Application
    • Diabetes
    • Heart Failure
    • Hypertension
    • Renal Failure
  • End-User
    • Ambulatory Care Centers
    • Diagnostic Centers & Hospitals
    • Research & Academia
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Renal Denervation Devices Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Renal Denervation Devices Market?

3. What are the technology trends and regulatory frameworks in the Renal Denervation Devices Market?

4. What is the market share of the leading vendors in the Renal Denervation Devices Market?

5. Which modes and strategic moves are suitable for entering the Renal Denervation Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of congestive chronic renal failure with aging population
      • 5.1.1.2. Growing adoption and inclination towards minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with renal denervation devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements and improvements in renal denervation devices
      • 5.1.3.2. Ongoing publishing of clinical guidelines for renal denervation and increasing clinical assessment studies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government regulations for product approval coupled with lack of experienced healthcare professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: High adoption of ultrasound-based renal denervation technology
    • 5.2.2. Product: Significant use of multi-electrode catheters for their shorter-time of procedures
    • 5.2.3. Disease Application: Proliferating use of renal denervation devices for treating hypertension
    • 5.2.4. End-User: Ambulatory care centers prioritize renal denervation devices as a minimally invasive and cost-effective solution
  • 5.3. Market Trend Analysis
    • 5.3.1. Favorable government approvals for renal denervation devices in the Americas backed by the presence of well-established medical device companies and rising medical professional acceptance
    • 5.3.2. Expanding government support to improve diagnosis and treatment of hypertension coupled with increasing positive results from clinical trials of renal denervation devices in the APAC region
    • 5.3.3. Supportive government initiatives and approval procedures for renal denervation devices across the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Renal Denervation Devices Market, by Technology

  • 6.1. Introduction
  • 6.2. Micro-Infusion-Based
  • 6.3. Pharmacologic Ablation
  • 6.4. Radiofrequency-Based
  • 6.5. Ultrasound-Based

7. Renal Denervation Devices Market, by Products

  • 7.1. Introduction
  • 7.2. Catheters
  • 7.3. Nerve Modifying Agents
  • 7.4. RF Generator

8. Renal Denervation Devices Market, by Disease Application

  • 8.1. Introduction
  • 8.2. Diabetes
  • 8.3. Heart Failure
  • 8.4. Hypertension
  • 8.5. Renal Failure

9. Renal Denervation Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Care Centers
  • 9.3. Diagnostic Centers & Hospitals
  • 9.4. Research & Academia

10. Americas Renal Denervation Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Renal Denervation Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Renal Denervation Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension
    • 13.3.2. FDA Approves Verve Medical's IDE Renal Pelvic Denervation Trial
    • 13.3.3. Korean Startup Kalos Gets USD 3.5 Million Grant to Develop Renal Denervation Device for hypertension Treatment
    • 13.3.4. Renal Denervation Using Ultrasound Ablation in Treatment-Resistant Hypertension is Being Evaluated for Early Benefit Assessment in Germany
    • 13.3.5. Andera Partners Invests in SoniVie, a Medtech Company Developing a Promising Device for the Treatment of Hypertension
    • 13.3.6. Transitional Coverage for Renal Denervation Catheter SYMPLICITY SPYRAL from Medtronic in France
    • 13.3.7. Shanghai Golden Leaf Med Tec Co., Ltd Secures Hundreds of Mns of CNY in Series C Round
    • 13.3.8. SPYRAL HTN-ON MED Study Demonstrates Meaningful Clinical Benefits Consistent with other SPYRAL HTN Renal Denervation Trials
    • 13.3.9. SoniVie Receives IDE Approval from FDA for its Pilot Study to Treat Hypertension with its Renal Artery Denervation TIVUS Technology
    • 13.3.10. Ablative Solutions Raises USD 91.4 Million in Series D Financing Round
    • 13.3.11. Clinical Accelerator Announces Collaboration with Verve Medical to Conduct an Early Human Feasibility Study for Treatment-Resistant Hypertension

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. RENAL DENERVATION DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. RENAL DENERVATION DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. RENAL DENERVATION DEVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 15. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 17. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 19. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 23. RENAL DENERVATION DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. RENAL DENERVATION DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RENAL DENERVATION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2018-2023 (USD THOUSAND)
  • TABLE 4. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, 2024-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 6. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 7. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 8. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 10. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MICRO-INFUSION-BASED, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 12. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PHARMACOLOGIC ABLATION, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 14. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RADIOFREQUENCY-BASED, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 16. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY ULTRASOUND-BASED, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 18. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 20. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 22. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 24. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY MULTI ELECTRODE CATHETER, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 26. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY SINGLE ELECTRODE CATHETER, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 27. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 28. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY NERVE MODIFYING AGENTS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 29. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 30. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RF GENERATOR, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 31. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 32. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 33. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 34. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 35. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 36. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 37. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 38. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY HYPERTENSION, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 39. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 40. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RENAL FAILURE, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 41. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 42. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 43. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 44. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 45. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 46. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & HOSPITALS, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 47. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2023 (USD THOUSAND)
  • TABLE 48. GLOBAL RENAL DENERVATION DEVICES MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2024-2030 (USD THOUSAND)
  • TABLE 49. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 50. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 51. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 52. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 53. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 54. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 55. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 56. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 57. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 58. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 59. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 60. AMERICAS RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 61. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 62. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 63. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 64. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 65. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 66. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 67. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 68. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 69. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 70. ARGENTINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 71. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 72. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 73. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 74. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 75. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 76. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 77. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 78. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 79. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 80. BRAZIL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 81. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 82. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 83. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 84. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 85. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 86. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 87. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 88. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 89. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 90. CANADA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 91. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 92. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 93. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 94. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 95. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 96. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 97. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 98. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 99. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 100. MEXICO RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 101. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 102. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 103. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 104. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 105. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 106. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 107. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 108. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 109. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 110. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 111. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2018-2023 (USD THOUSAND)
  • TABLE 112. UNITED STATES RENAL DENERVATION DEVICES MARKET SIZE, BY STATE, 2024-2030 (USD THOUSAND)
  • TABLE 113. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 114. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 115. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 116. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 117. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 118. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 119. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 120. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 121. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 122. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 123. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 124. ASIA-PACIFIC RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 125. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 126. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 127. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 128. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 129. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 130. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 131. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 132. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 133. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 134. AUSTRALIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 135. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 136. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 137. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 138. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 139. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 140. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 141. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 142. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 143. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 144. CHINA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 145. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 146. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 147. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 148. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 149. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 150. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 151. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 152. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 153. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 154. INDIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 155. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 156. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 157. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 158. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 159. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 160. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 161. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 162. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 163. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 164. INDONESIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 165. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 166. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 167. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 168. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 169. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 170. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 171. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 172. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 173. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 174. JAPAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 175. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 176. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 177. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 178. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 179. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 180. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 181. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 182. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 183. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 184. MALAYSIA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 185. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 186. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 187. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 188. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 189. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 190. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 191. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 192. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 193. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 194. PHILIPPINES RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 195. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 196. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 197. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 198. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 199. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 200. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 201. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 202. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 203. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 204. SINGAPORE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 205. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 206. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 207. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 208. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 209. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 210. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 211. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 212. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 213. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 214. SOUTH KOREA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 215. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 216. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 217. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 218. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 219. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 220. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 221. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 222. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 223. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 224. TAIWAN RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 225. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 226. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 227. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 228. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 229. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 230. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 231. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 232. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 233. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 234. THAILAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 235. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 236. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 237. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 238. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 239. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 240. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 241. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 242. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 243. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 244. VIETNAM RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD THOUSAND)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA RENAL DENERVATION DEVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD THOUSAND)
  • TABLE 257. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 258. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 259. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 260. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 261. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 262. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 263. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 264. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 265. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 266. DENMARK RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 267. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 268. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 269. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 270. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 271. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 272. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 273. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 274. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 275. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 276. EGYPT RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 277. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 278. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 279. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 280. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 281. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 282. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 283. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 284. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 285. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 286. FINLAND RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 287. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 288. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 289. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 290. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 291. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 292. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 293. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 294. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 295. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 296. FRANCE RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 297. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 298. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 299. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 300. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 301. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 302. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 303. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 304. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 305. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 306. GERMANY RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 307. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 308. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 309. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 310. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 311. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 312. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 313. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 314. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 315. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2018-2023 (USD THOUSAND)
  • TABLE 316. ISRAEL RENAL DENERVATION DEVICES MARKET SIZE, BY END-USER, 2024-2030 (USD THOUSAND)
  • TABLE 317. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD THOUSAND)
  • TABLE 318. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD THOUSAND)
  • TABLE 319. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2018-2023 (USD THOUSAND)
  • TABLE 320. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY PRODUCTS, 2024-2030 (USD THOUSAND)
  • TABLE 321. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2018-2023 (USD THOUSAND)
  • TABLE 322. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY CATHETERS, 2024-2030 (USD THOUSAND)
  • TABLE 323. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2018-2023 (USD THOUSAND)
  • TABLE 324. ITALY RENAL DENERVATION DEVICES MARKET SIZE, BY DISEASE APPLICATION, 2024-2030 (USD THOUSAND)
  • TABLE 325. ITALY RENAL DENERVATION DEVICES MARKE